Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
The Patient Engagement Collaborative will bring together the patient community and regulators to discuss patient engagement across #FDA Centers. https://t.co/gT3y6YUz8e
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSGov: #Mumps outbreaks can occur in places where people have had prolonged, close contact with a person who has mumps, li… https://t.co/pFngQd0gOz
SteveFDA (R-D.C.)
@SGottliebFDA
FDA and the @EU took important steps to reopen shellfish trade that could mutually benefit our economies while maintaining high levels of safety for imported shellfish: https://t.co/mJWv0MTiTm https://t.co/bXqQegkx2h
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: Review of This Year’s Severe Flu Season: @CDCgov, @US_FDA, @NIH and @BARDA Officials Discuss | #Regulatory Focus… https://t.co/juAVTJqoHs
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HouseCommerce: #SubOversight gets an update on seasonal flu & vaccine improvements >> https://t.co/8D9bd1X6QR
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA discusses important Rx drug promotion social science research in the upcoming year at @DrugInfoAssn #AdPromo18. Topics include a focus on effectiveness of disclosures and communications with health care providers https://t.co/SLeqEG64wZ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @statnews: Scott Gottlieb says the way biosimilar drugs are paid for is "rigged" — ultimately, keeping them out of patients' r… https://t.co/8AAOTnaBXj
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is committed to finding paths to make it more efficient for LDTs to seek voluntary clearance; and ultimately we’re seeking legislation for a regulatory path that’s properly tailored to these unique, promising technologies https://t.co/ORLGmHNWBK
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: Unable to attend #SRNT2018? Don’t worry – you can watch FDA Commissioner @SGottliebFDA’s keynote here:… https://t.co/fZgpulkz4K
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HelenBranswell: Flu vaccine made in cell culture worked measurably better than standard egg-based vaccines this year - a 20% boost,… https://t.co/TBFAKqu2Yu
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAfood: Public comment period is open for the FDA’s proposed determination of equivalence for the EU (@EU_Commission)… https://t.co/vp59ofcGRF
SteveFDA (R-D.C.)
@SGottliebFDA
RT @dgingery: Bonus Friday reading: Gene Therapy Manufacturing Remains Large Hurdle For Development, US #FDA's CBER Director Says https://t.co/ZwwE6cbei8
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SeanKhozin: #SmartRegulation in action- protects patients and consumers while creating new paths for #innovation https://t.co/oKBbrxV2Wn QT @SGottliebFDA: #FDA is committed to finding paths to make it more efficient for LDTs to seek voluntary clearance; and ultimately w… https://t.co/C6Tp0chynF)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA warns duodenoscope manufacturers about failure to comply with required postmarket surveillance studies to asses… https://t.co/eyeFcl5SCq
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSMedia: Video: New HHS Secretary @SecAzar Takes on the Opioid Crisis https://t.co/CXVwHWTVZ4 via @FoxNews
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Track: FDA warns #duodenoscope manufacturers about failure to comply with required postmarket surveillance studies to asse… https://t.co/CFxMMSfWMR
SteveFDA (R-D.C.)
@SGottliebFDA
Another company has voluntarily recalled certain kratom products due to possible salmonella contamination. https://t.co/lGWYa3byhc
SteveFDA (R-D.C.)
@SGottliebFDA
Due to the scientific evidence of the serious risks associated with the use of kratom, #FDA continues to urge all companies selling kratom to remove their products from the market and consumers not to use any kratom products. https://t.co/rSsLSgNwbN
SteveFDA (R-D.C.)
@SGottliebFDA
FDA recognizes American National Standards Institute as the 2nd accreditation body under #FSMA Third-Party Accreditation Program #TAP validated thru application review and on-site assessment https://t.co/snuQezSwr6 https://t.co/ff2QDFwwDW
SteveFDA (R-D.C.)
@SGottliebFDA
Kratom should not be used to treat medical conditions or as an alternative to Rx opioids. https://t.co/rSsLSgNwbN